Goldman Sachs’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-30,000	Closed	-$946K	–	5270
2020 Q1	$946K	Buy	+30,000	New	+$1.58M	﹤0.01%	3802
2018 Q1	–	Sell	-2,200	Closed	-$145K	–	6006
2017 Q4	$145K	Sell	2,200 -16,300	-88%	-$878K	﹤0.01%	5572
2017 Q3	$927K	Sell	18,500 -20,300	-52%	-$979K	﹤0.01%	4639
2017 Q2	$1.8M	Buy	38,800 +12,500	+48%	+$460K	﹤0.01%	3926
2017 Q1	$929K	Buy	26,300 +12,700	+93%	+$291K	﹤0.01%	4448
2016 Q4	$170K	Buy	13,600 +1,300	+11%	+$15.5K	﹤0.01%	5873
2016 Q3	$170K	Buy	12,300 +7,600	+162%	+$86.1K	﹤0.01%	5925
2016 Q2	$46K	Sell	4,700 -40,600	-90%	-$673K	﹤0.01%	6454
2016 Q1	$766K	Sell	45,300 -8,000	-15%	-$129K	﹤0.01%	4323
2015 Q4	$1.19M	Sell	53,300 -44,800	-46%	-$1.13M	﹤0.01%	4130
2015 Q3	$2.31M	Sell	98,100 -373,500	-79%	-$23.4M	﹤0.01%	3638
2015 Q2	$38.6M	Buy	471,600 +470,500	+42,773%	+$46.1M	0.01%	1303
2015 Q1	$102K	Buy	+1,100	New	+$71K	﹤0.01%	6416